Blockchain Registration Transaction Record

Lexaria Bioscience Reports Noteworthy Results from WEIGHT-A24-1 Animal Study

Lexaria Bioscience reports significant milestone in drug-delivery technology with WEIGHT-A24-1 animal study results

Lexaria Bioscience Reports Noteworthy Results from WEIGHT-A24-1 Animal Study

This news matters as it represents a significant milestone for Lexaria Bioscience in the potential treatment of diabetes and weight loss. The company's patented DehydraTECH technology has demonstrated the ability to improve drug delivery and increase bioabsorption, which could have a far-reaching impact on the treatment of various medical conditions.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xf24790f58079ef23ed2a833fa1dd396fb680bc8e37dad45ce5b9a7084490f942
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintricebTsg-6607f4590f3098456cd5b8233e8511c4